IVBT — Innovation1 Biotech Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual balance sheet for Innovation1 Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	2021 August 31st	2022 August 31st	2023 August 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K		10-K	10-K
Standards:	USG	USG	—	USG	USG
Status:	Final	Final	fx Preliminary	Final	Final
Cash
Cash and Short Term Investments	0.019	0.018	—	0.156	0.05
Net Total Accounts Receivable
Net Total Receivables	0	0.133	—	0.056	0.008
Total Inventory
Prepaid Expenses
Total Current Assets	0.248	0.202	—	0.287	0.073
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.007	0.002	—	0.485	0.002
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	0.256	0.209	—	44	0.076
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.224	2.89	—	29.8	3.29
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.224	2.89	—	41.1	3.51
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.032	-2.68	—	2.85	-3.43
Total Liabilities & Shareholders' Equity	0.256	0.209	—	44	0.076
Total Common Shares Outstanding
Total Preferred Shares Outstanding